Table 3 Comparisons of actionable genes and called variants across clinical study groups. Only breast cancers with at least one variant were counted

Whole cohort

Actionable genes

1.4

0.6

1

4

Called variants

3.2

9.1

1

96

Group 1A

Actionable genes

1.4

0.6

1

3

Called variants

1.9

1.0

1

6

Group 1B

Actionable genes

2.1*

1.0

1

4

Called variants

16.9*

23.8

1

64

Group 2

Actionable genes

1.4

0.6

1

3

Called variants

11.1

20.4

1

80

Group 3–1

Actionable genes

1.5

0.7

1

3

Called variants

1.8

1.0

1

4

Group 3–2

Actionable genes

1.4

0.5

1

2

Called variants

1.6

0.9

1

3

Biobank

Actionable genes

1.5

0.6

1

4

Called variants

5.5

18.1

1

96